Delivra Health Brands Stock Performance
| DHBUF Stock | USD 0.01 0.0003 2.65% |
The firm shows a Beta (market volatility) of 0.007, which means not very significant fluctuations relative to the market. As returns on the market increase, Delivra Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Delivra Health is expected to be smaller as well. At this point, Delivra Health Brands has a negative expected return of -0.31%. Please make sure to confirm Delivra Health's total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if Delivra Health Brands performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Delivra Health Brands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 4.4 M | |
| Total Cashflows From Investing Activities | 1.4 M |
Delivra |
Delivra Health Relative Risk vs. Return Landscape
If you would invest 1.73 in Delivra Health Brands on September 20, 2024 and sell it today you would lose (0.63) from holding Delivra Health Brands or give up 36.42% of portfolio value over 90 days. Delivra Health Brands is currently producing negative expected returns and takes up 9.2789% volatility of returns over 90 trading days. Put another way, 82% of traded otc stocks are less volatile than Delivra, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Delivra Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Delivra Health's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Delivra Health Brands, and traders can use it to determine the average amount a Delivra Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0333
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DHBUF |
Estimated Market Risk
| 9.28 actual daily | 82 82% of assets are less volatile |
Expected Return
| -0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Delivra Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Delivra Health by adding Delivra Health to a well-diversified portfolio.
Delivra Health Fundamentals Growth
Delivra OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Delivra Health, and Delivra Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Delivra OTC Stock performance.
| Return On Equity | -1.01 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.77) % | |||
| Operating Margin | (0.66) % | |||
| Current Valuation | 4.15 M | |||
| Shares Outstanding | 252.62 M | |||
| Price To Book | 1.66 X | |||
| Price To Sales | 0.48 X | |||
| Revenue | 8.14 M | |||
| EBITDA | (4.25 M) | |||
| Cash And Equivalents | 1.67 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.67 M | |||
| Debt To Equity | 0.38 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (4.44 M) | |||
| Total Asset | 11.59 M | |||
About Delivra Health Performance
By analyzing Delivra Health's fundamental ratios, stakeholders can gain valuable insights into Delivra Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Delivra Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Delivra Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada. Delivra Health is traded on OTC Exchange in the United States.Things to note about Delivra Health Brands performance evaluation
Checking the ongoing alerts about Delivra Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Delivra Health Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Delivra Health generated a negative expected return over the last 90 days | |
| Delivra Health has high historical volatility and very poor performance | |
| Delivra Health has some characteristics of a very speculative penny stock | |
| Delivra Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 8.14 M. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 2.6 M. | |
| Delivra Health Brands has accumulated about 1.67 M in cash with (4.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 22.0% of the company shares are held by company insiders |
- Analyzing Delivra Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Delivra Health's stock is overvalued or undervalued compared to its peers.
- Examining Delivra Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Delivra Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Delivra Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Delivra Health's otc stock. These opinions can provide insight into Delivra Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Delivra OTC Stock analysis
When running Delivra Health's price analysis, check to measure Delivra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delivra Health is operating at the current time. Most of Delivra Health's value examination focuses on studying past and present price action to predict the probability of Delivra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delivra Health's price. Additionally, you may evaluate how the addition of Delivra Health to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |